buthionine sulfoximine glutathione resistant human breast cancer cells Sigma-Aldrich ʟ-Buthionine-sulfoximine, CAS 83730-53-4, ≥97%
Sigma Aldrich Buthionine sulfoximine, CAS 83730 53 4, 97% (TLC) 500 mg Buthionine Sulfoximine an overview ScienceDirect Topics DL Buthionine (S,R) sulfoximine 5072 26 4 Frontiers Systemic L Buthionine S R Sulfoximine Treatment Increases Plasma NGF and Upregulates L cys L cys2 Transporter and Glutamylcysteine Ligase mRNAs Through the NGF TrkA Akt Nrf2 Pathway in the Striatum
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



